Cargando…
High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647974/ https://www.ncbi.nlm.nih.gov/pubmed/38028672 http://dx.doi.org/10.1002/hsr2.1685 |
_version_ | 1785147533277790208 |
---|---|
author | Lionello, Federico Guarnieri, Gabriella Arcaro, Giovanna Vianello, Andrea |
author_facet | Lionello, Federico Guarnieri, Gabriella Arcaro, Giovanna Vianello, Andrea |
author_sort | Lionello, Federico |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10647974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106479742023-11-15 High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study Lionello, Federico Guarnieri, Gabriella Arcaro, Giovanna Vianello, Andrea Health Sci Rep Research Letter John Wiley and Sons Inc. 2023-11-15 /pmc/articles/PMC10647974/ /pubmed/38028672 http://dx.doi.org/10.1002/hsr2.1685 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Letter Lionello, Federico Guarnieri, Gabriella Arcaro, Giovanna Vianello, Andrea High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study |
title | High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study |
title_full | High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study |
title_fullStr | High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study |
title_full_unstemmed | High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study |
title_short | High flow nasal oxygen as a “second‐line” therapy for COVID‐19 patients intolerant to noninvasive ventilation. A retrospective cohort study |
title_sort | high flow nasal oxygen as a “second‐line” therapy for covid‐19 patients intolerant to noninvasive ventilation. a retrospective cohort study |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647974/ https://www.ncbi.nlm.nih.gov/pubmed/38028672 http://dx.doi.org/10.1002/hsr2.1685 |
work_keys_str_mv | AT lionellofederico highflownasaloxygenasasecondlinetherapyforcovid19patientsintoleranttononinvasiveventilationaretrospectivecohortstudy AT guarnierigabriella highflownasaloxygenasasecondlinetherapyforcovid19patientsintoleranttononinvasiveventilationaretrospectivecohortstudy AT arcarogiovanna highflownasaloxygenasasecondlinetherapyforcovid19patientsintoleranttononinvasiveventilationaretrospectivecohortstudy AT vianelloandrea highflownasaloxygenasasecondlinetherapyforcovid19patientsintoleranttononinvasiveventilationaretrospectivecohortstudy |